Single award · contract
Contract HHSO100201700016C
Award ID: HHSO100201700016C
A single federal award, with both ends of the trail linked.
$973.6M
Total award value
Award HHSO100201700016C is a contract from the Department of Health and Human Services to Regeneron Pharmaceuticals Inc, $973.6M obligated, FY2017 to FY2031. The work is performed in New York. It is classified as PSC AN13 (Health R&D Services; Health Care Services; Experimental Development) and NAICS 541711 (Research and Development in Biotechnology). Source
Description
Igf::ot::igf
Award details
Award typeContract
PIIDHHSO100201700016C
Action date2017
Period168 mo
Awarding agencyDepartment of Health and Human Services →
RecipientRegeneron Pharmaceuticals Inc →
Place of performanceNew York →
CategoryPSC AN13NAICS 541711
Competed?Not recordedSource
Total (exact)$973,560,407
More awards to Regeneron Pharmaceuticals Inc
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.